戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 utaneous vaccine with respect to the rate of seropositivity.
2 rology, likely due to the high prevalence of seropositivity.
3  magnetic resonance imaging, correlated with seropositivity.
4 e also evaluated factors associated with HEV seropositivity.
5 s, only older age remained predictive of HEV seropositivity.
6 ost significant risk factors associated with seropositivity.
7 continues to challenge the interpretation of seropositivity.
8 xposure is independently associated with HPV seropositivity.
9 for human papillomavirus (HPV)-16 and HPV-18 seropositivity.
10 nce of H1N1pdm09 vaccination or pre-pandemic seropositivity.
11  were strongly associated with post-pandemic seropositivity.
12 fer significantly according to recipient CMV seropositivity.
13  recent seroconversion, as well as sustained seropositivity.
14 als) as witnessed by their hepatitis C virus seropositivity.
15 n in Brazil, both tests detected 28%(n = 17) seropositivity.
16 tients had titers considered at baseline for seropositivity.
17  (1.9%) and other species exhibiting </=0.6% seropositivity.
18 al pathogen-specific antibody was considered seropositivity.
19 cantly associated with increased odds of HEV seropositivity.
20  fetal immunoglobulin M (IgM) umbilical cord seropositivity.
21 alarials were associated with HCV subtype 4k seropositivity.
22 ause survival in relation to HPV16 E6 and E7 seropositivity.
23 nd individual characteristics that relate to seropositivity.
24 ated with increasing age and cytomegalovirus seropositivity.
25 ere associated with 16/18 and 31/33/45/52/58 seropositivity.
26  and B-cell proportions by BK, JC, and HPyV9 seropositivity.
27 ause survival in relation to HPV16 E6 and E7 seropositivity.
28  HBV genotype C infection and maternal HBsAg seropositivity.
29 = 1.7 x 10(-8)), to be associated with HPV77 seropositivity.
30  memory was exhibited by 45% on the basis of seropositivity 1 week after vaccination and by 29% on th
31 usion criteria were as follows: (1) AQP4-IgG seropositivity, (2) myelitis attack and (3) MRI spinal c
32                                  The highest seropositivity (25/155) was observed within the age grou
33 %-70%] vs 98% [95% CI, 95%-100%]), and mumps seropositivity (59% [95% CI, 55%-64%] vs 97% [95% CI, 94
34 ine response occurred in 46% on the basis of seropositivity 8 weeks after vaccination and in 37% on t
35 assay (ELISA) thresholds for HPV16 and HPV18 seropositivity (8 and 7 ELISA units/mL, respectively, fo
36                                          CMV seropositivity accentuates further the accumulation of h
37 2.36) and inversely associated with SE36IgG1 seropositivity (adjusted OR: 0.37; 95% CI 0.21-0.64) and
38 BL was positively associated with HRP-IIIgG3 seropositivity (adjusted OR: 1.60; 95% CI 1.08-2.36) and
39                                              Seropositivity after 1 vaccine dose among children with
40 atitis A virus (anti-HAV) on the duration of seropositivity after hepatitis A vaccination during infa
41                                    H. pylori seropositivity also was inversely related to recent whee
42                    Although the frequency of seropositivity among all participants through age 10 yea
43                    Independent predictors of seropositivity among children with PHIV were receipt of
44  B. pseudomallei from a soil sample and high seropositivity among patient contacts suggest at least r
45                                              Seropositivity among recipients of 2 vaccine doses was >
46 ted an age-dependent association between HCV seropositivity and albuminuria (adjusted odds ratios and
47 al association between prevalent hepatitis C seropositivity and albuminuria and estimated GFR (eGFR),
48  a significantly higher risk of toxocariasis seropositivity and Anisakis simplex sensitization when c
49 prevalence of Toxocara spp. and Ascaris spp. seropositivity and associations with allergic diseases a
50 ort an inverse association between H. pylori seropositivity and asthma in children.
51 observed associations between genus-beta HPV seropositivity and BCC.
52 no association was observed between beta-HPV seropositivity and beta-HPV DNA-negative BCC.
53 ically significant association between HSV-2 seropositivity and CD4 count over time, but this differe
54 to examine the associations between pathogen seropositivity and cognitive impairment.
55 ion that showed association between anti-HEV seropositivity and functional epsilon3 and epsilon4 alle
56       Within the RA group, rheumatoid factor seropositivity and higher cumulative prednisone exposure
57                                              Seropositivity and higher IgG antibody levels against CM
58                       Prevalence of paternal seropositivity and incidence of recent infection were ca
59                                          CMV seropositivity and lack of aggressive CMV prophylaxis co
60 ant recipient cytomegalovirus (CMV) antibody seropositivity and lack of aggressive prophylaxis agains
61 ificant association observed for hepatitis C seropositivity and low eGFR (<60 ml/min per 1.73 m(2); a
62 ns in p53 degradation, we evaluated HPV16 L1 seropositivity and MDM2 promoter variants to examine the
63 nce of a significant association between HIV seropositivity and OSSN.
64 ates the association between cytomegalovirus seropositivity and outcome in a large population of noni
65            Epidemiological surveys for MCPyV seropositivity and sequencing analyses of healthy human
66 was no significant association between HSV-2 seropositivity and the presence of fibroids (multivariab
67 ical information on the relationship between seropositivity and toxocariasis is limited.
68                       No concordance between seropositivity and tumor DNA status was observed for HPV
69 ion less than 3 vertebral segments, AQP4-IgG seropositivity, and a final diagnosis of NMO or NMOSD.
70 C-reactive protein levels, rheumatoid factor seropositivity, and a lack of current treatment with dis
71 nfection with a detectable viral load, HBeAg seropositivity, and absence of HIV infection.
72  tuberculosis infection, hepatitis B and HIV seropositivity, and child and adult vaccination needs th
73 90 and were followed for analysis of safety, seropositivity, and neutralizing antibodies to DENV-1-4.
74 ptic neuritis, transverse myelitis, AQP4-IgG seropositivity, and recurrent myalgias with hyperCKemia.
75 hyroid peroxidase, and anti-transglutaminase seropositivity, and these autoantibodies did not correla
76 tenatal care coverage, and syphilis testing, seropositivity, and treatment in antenatal care.
77                                              Seropositivity (anti-HAV >/=20 mIU/mL) 30 years after th
78 ransplant recipients that betapapillomavirus seropositivity around transplantation significantly incr
79 es to assess risk factors for human MERS-CoV seropositivity at a farm complex in Qatar.
80                              Determinants of seropositivity at age 4 were cord seropositivity (JCPyV,
81  robust variance to identify determinants of seropositivity at age 4.
82 iable DRB locus within the MHC region to HPV seropositivity at both the individual HPV type level and
83 gated whether neuromyelitis optica (NMO) IgG seropositivity at the initial presentation of longitudin
84 sed by occupational flour exposure and wheat seropositivity based on cross-reactivity to grass pollen
85 f 225 children was evaluated for CMV and EBV seropositivity before 2 years of age and for vaccination
86                                    Measuring seropositivity before vaccine introduction provides base
87 screening study of various NAbs showed 22.5% seropositivity belonging mostly to VGKC-complex antibodi
88 ere analyzed to examine risk factors for EBV seropositivity, both overall and by EBV type.
89 n assay and rubella seroprotection and mumps seropositivity by enzyme immunoassay.
90 h neurobehavioral disease is associated with seropositivity, causality is unproven.
91                               Persistence of seropositivity conferred by hepatitis A vaccine administ
92                                              Seropositivity correlated directly with exposure risk in
93 plantation and that cytomegalovirus antibody seropositivity correlated with increased negative remode
94                                     Rates of seropositivity depended on the population, HPV type, and
95                       Donor and recipient JC seropositivity did not predict BK viruria or viremia.
96  cancer risk factors with genus-specific HPV seropositivity differed by sex.
97                                              Seropositivity distinguishes autoimmune glial fibrillary
98                  Recipient hepatitis C virus seropositivity, donor age, donor cause of death, and lif
99                     Type-specific persistent seropositivity entailed elevated point estimates for SCC
100                          Helicobacter pylori seropositivity, especially H. pylori cagA positivity, wa
101 were significantly associated with TES-ELISA seropositivity except vitreits (X(2) = 8.557, p = 0.003)
102                  The primary end points were seropositivity for antibodies against measles and advers
103 nfluenza A(H7N9) infection in China found no seropositivity for antibodies specific for avian-origin
104 c groups, the number (weighted frequency) of seropositivity for antibody to HAV was 958 (24.9%), 802
105                                  In summary, seropositivity for certain HPV types was associated with
106                  We aimed to examine whether seropositivity for CMV and the level of CMV immunoglobul
107                                              Seropositivity for CMV or EBV infection alters B cell re
108          T-cell subsets and immunoglobulin G seropositivity for CMV, EBV, herpes-simplex virus 1, and
109                      In the discovery study, seropositivity for cytomegalovirus (CMV) in donors or re
110  for at least 1 of the 6 HY-Abs, and 3-month seropositivity for each HY-Ab was associated with a pers
111                                              Seropositivity for hepatitis C virus (HCV) predicts lowe
112                      The prevalence ratio of seropositivity for HIV-positive females versus HIV-negat
113                                              Seropositivity for HPV types in genera alpha or beta inc
114 l associations were observed between BCC and seropositivity for HPV types in genus-alpha (odds ratio
115                                Prevalence of seropositivity for human CMV increases with age.
116                                 Infant HBsAg seropositivity for more than 6 months was defined as chr
117                                              Seropositivity for pgp3 antibody varied from 1.4% (95% C
118 itis in patients with RA was associated with seropositivity for RF and the anti-CCP antibody, which w
119 ubset of patients studied for all endpoints, seropositivity for the E6 and E7 proteins was significan
120 (odds ratio, 12.3; 95% CI, 5.4 to 26.4), and seropositivity for the HPV-16 L1 capsid protein (odds ra
121                                              Seropositivity for tTGA resolved spontaneously, without
122 roup, antirotavirus immunoglobulin A and IgG seropositivity frequencies before vaccination (52.7% and
123             Two doses of the vaccine yielded seropositivity frequencies of 92.3%, 95.9%, and 99.0% (w
124 ore, patients with p16 staining and E6 or E7 seropositivity had favorable survival from oropharyngeal
125                                          EBV seropositivity has been connected to immunomodulatory ef
126 year among those with donor or recipient CMV seropositivity (hazard ratio 2.0: 95% confidence interva
127 mortality included recipient cytomegalovirus seropositivity (HR 1.40, 95% CI 1.13-1.74, p=0.0020), re
128 % CI 1.1 to 1.2; P = 0.004), and hepatitis C seropositivity (HR 2.8; 95% CI 1.1 to 7.0; P = 0.03) wer
129                                        HHV-8 seropositivity in children was independently associated
130 associated with genus-specific cutaneous HPV seropositivity in men and women.
131       Our findings suggest that baseline HPV seropositivity in men is not associated with reduced ris
132 e factors associated with genus-specific HPV seropositivity in men.
133 single-nucleotide polymorphisms and anti-HEV seropositivity in non-Hispanic blacks or between any sin
134 single-nucleotide polymorphisms and anti-HEV seropositivity in non-Hispanic whites or Mexican America
135                   This high rate of Toxocara seropositivity in ocular patients should alert ophthalmo
136                                          CMV seropositivity in other conditions is associated with ar
137 ce of immunoblot-confirmed B burgdorferi IgG seropositivity in our uveitis patients is only slightly
138  over years, and prolonged waxing and waning seropositivity in some subjects, raises the possibility
139            Independent predictors of measles seropositivity in the 1967-1976 birth cohort were non-Hi
140 ncaster, we confirm previous observations of seropositivity in the majority of the population.
141        During 1999-2004, the rate of measles seropositivity in the population overall was 95.9% (95%
142 olor were associated with genus-specific HPV seropositivity in women.
143                      Risk factors for HTLV-1 seropositivity included intravenous injections at hospit
144 strata, and analyzed factors associated with seropositivity, including age, gravidity, human immunode
145                                              Seropositivity increased slightly with age in only one d
146 respectively), whereas donor cytomegalovirus seropositivity increased the risk for late-onset IA (ie,
147                                              Seropositivity increased with increasing days of illness
148  antibody to HEV (anti-HEV) immunoglobulin G seropositivity indicating past or recent HEV infection a
149                                          The seropositivity induced by hepatitis A vaccine given to c
150  wave rose to 23%, either due to prepandemic seropositivity, infection or vaccination.
151 omarker of Epstein-Barr virus (anti-EBNA IgG seropositivity), infectious mononucleosis, and smoking s
152 immunodeficiency virus (HIV) and hepatitis B seropositivity, intestinal parasite test positivity, nee
153                               JC virus (JCV) seropositivity is a risk factor for progressive multifoc
154         In the postvaccination era, anti-HBc seropositivity is a useful marker for OBI screening in H
155 eroprevalence rate of 36%, we find that HCMV seropositivity is associated with lower NK cell IFN-gamm
156                                              Seropositivity is associated with neurologic diseases an
157                Our findings suggest that PyV seropositivity is common in the United States and varies
158 ssociation noted between rs41270488 and HPV8 seropositivity is driven by two independent variants, na
159                                         High seropositivity is found in horses worldwide with approxi
160 tributable fraction of FGC for prevalent HCV seropositivity is high in women (79.8%).
161 at the risk of OSCC associated with HPV16 L1 seropositivity is modified by MDM2 promoter polymorphism
162         Adeno-associated virus type 2 (AAV2) seropositivity is negatively correlated with the develop
163                                              Seropositivity is now incorporated into new diagnostic c
164                                     HPV16 E6 seropositivity is relatively common before diagnosis of
165  We conclude that donor and/or recipient CMV seropositivity is still associated with an adverse progn
166                                          CMV seropositivity itself was not a risk factor for infectio
167 minants of seropositivity at age 4 were cord seropositivity (JCPyV, HPyV7, HPyV10, CMV), vaginal deli
168 born during 1967-1976 had the lowest measles seropositivity levels and represent populations that mig
169 population subgroups had evidence of measles seropositivity levels greater than the estimated thresho
170 galovirus (CMV)-specific cells, although CMV seropositivity modulated the distribution of lymphocyte
171 e agents (n = 8), and reported anti-JC virus seropositivity (n = 13).
172 h was significantly different from the 53.6% seropositivity observed in the overall MS study populati
173 icient 0.54; p<0.0001) and increased odds of seropositivity (odds ratio 1.59 [95% CI 1.1-2.3]) adjust
174 ntly associated with a CD4/CD8 ratio <1: CMV seropositivity (odds ratio [OR], 1.9 [95% confidence int
175 s, 19.5% (22 of 113) for blood samples, with seropositivity of 62.8% (71 of 113 samples) and with inc
176 inked immunosorbent assay (ELISA), we obtain seropositivity of 77%.
177 s with chronic urticaria more frequently had seropositivity of fasciolosis, Anisakis simplex sensitiz
178 ow specificity in areas where the background seropositivity of healthy people is high.
179       The negative prognostic effects of CMV seropositivity of the donor and/or the recipient (vs CMV
180  from a CMV-seronegative donor, cases of CMV seropositivity of the donor and/or the recipient showed
181    The authors estimated the effect of HSV-2 seropositivity on HIV RNA viral load and on CD4 count ov
182 inically meaningful effect of baseline HSV-2 seropositivity on the trajectories of HIV plasma viral l
183 s found no associations between maternal IgG seropositivity or antibody levels to herpes simplex viru
184 determine the association between cord serum seropositivity or detectable C-reactive protein and NICU
185   We found no associations between H. pylori seropositivity overall either by whole-cell ELISA test o
186 me sex partners and HIV infection) and HHV-8 seropositivity (P > .10).
187  a significantly greater decline in GFR than seropositivity (P < 0.01).
188 ic CD8(+) T-cell analysis (P = .05), and CMV seropositivity (P = .01) were associated with a higher p
189 FoxP3 PTLDs were associated with hepatitis C seropositivity (P = 0.03).
190 otypes of the two polymorphisms and HPV16 L1 seropositivity (P(int) = 0.060 for MDM2-rs2279744, P(int
191 flammatory markers, disease activity scores, seropositivity, physical disability, destructive changes
192 95% confidence interval, 1.30-23.62), as did seropositivity (positive likelihood ratio, 3.69 [1.67-8.
193                                              Seropositivity predictors were identified using multivar
194                                          CMV seropositivity (prevalence 59%) was associated with incr
195  was assigned to estimate the probability of seropositivity prior to antibody test results.
196                      By using known anti-HBc seropositivity rate in children in our serosurveys, the
197 4-IgG positive, yielding an overall AQP4-IgG seropositivity rate of 89%.
198 nfection in fathers, relative to the average seropositivity rate of 9.8% for boys and men aged 12-49
199        BK polyomavirus is ubiquitous, with a seropositivity rate of over 75% in the adult population.
200                   The observed perinatal HCV seropositivity rate was compared to the expected rate (5
201                                              Seropositivity rates 2 months after 2 doses of IPV were
202                                              Seropositivity rates and corresponding geometric mean ti
203                    No differences existed in seropositivity rates by sex, age, age at receipt of the
204                              Expected infant seropositivity rates reached 80% vs 55% following second
205                                     Although seropositivity rates remained similarly high (48 [94%] o
206 imary endpoint were GMCs and expected infant seropositivity rates, defined by birth anti-PT >30 enzym
207                              Vaccine-induced seropositivity/reactivity, defined as reactive on 1 or m
208  Recurrent hyperCKemia accompanying AQP4-IgG seropositivity reflects targeting of skeletal muscle AQP
209                                 Neighborhood seropositivity results guided soil sampling to isolate B
210 efined by infant hepatitis B surface antigen seropositivity (risk ratio = 0.3, 95% confidence interva
211 nfidence interval 0.2-0.4) or infant HBV DNA seropositivity (risk ratio = 0.3, 95% confidence interva
212 netheless, the model indicated that anti-HAV seropositivity should persist for >/=30 years after vacc
213                                     HPV16 E6 seropositivity tended to increase in blood samples drawn
214 resulted in outer surface protein A-specific seropositivity that led to reductions of 23% and 76% in
215 those with both the TT genotype and HPV16 L1 seropositivity, the associated OR was 5.57 (95% CI, 2.93
216  childhood available for sampling maintained seropositivity through age 15-16 years; however, seropos
217 g/fall waves of the pandemic for evidence of seropositivity (titer >/=40) using the hemagglutination
218                 A fourth QHPV dose increased seropositivity to >/=96% for all vaccine genotypes.
219  We used a multiplex panel to assess whether seropositivity to 15 Helicobacter pylori proteins was as
220 herefore investigated whether preexisting Ad seropositivity to 7 different Ad serotypes was associate
221               The age-adjusted prevalence of seropositivity to A(H1N1)pdm09 by year-end 2009 was 36.9
222 owever, 69%-74% of children maintained their seropositivity to AMA1 alleles and 42%-52% to MSP2 allel
223                                              Seropositivity to avian influenza (AI) via low-level ant
224 associations with gastric adenocarcinoma and seropositivity to different Helicobacter pylori antigens
225                               These were IgG seropositivity to Epstein-Barr virus nuclear antigen (EB
226                                              Seropositivity to H. pylori proteins was associated with
227                                              Seropositivity to H. pylori was assessed using both mult
228 stitution (N145K/R) was sufficient to affect seropositivity to H3N2v viruses in some individuals.
229  of HIV-infected patients exhibit persistent seropositivity to HIV-1 and evidence of immune activatio
230 imens for HPV DNA or included assessments of seropositivity to HPV type 6, 11, 16, or 18 in men.
231                                     Baseline seropositivity to HPV types in genus beta species 2 was
232                                              Seropositivity to JC, MCV, and HPyV7 increased with age.
233 sorbent assay (ELISA) (HPV16 and HPV18 only) seropositivity to measures of HPV exposure, HPV DNA posi
234                                              Seropositivity to more herpesviruses was additively asso
235 the Step study, we observed that preexisting seropositivity to multiple Ad serotypes was not intrinsi
236                                              Seropositivity to PVs was associated with increasing age
237 onclusions, our cross-sectional study showed seropositivity to the NT5c1A antibody is associated with
238  in Japan and the United States, despite low seropositivity to TSST-1 in Japan.
239 ip between total infectious burden (additive seropositivity to various microbes) and cognition/AD.
240  immunosorbent assay units (EU)/mL to confer seropositivity until 3 months of age.
241                           After 2 TDV doses, seropositivity was >95% in all 5 groups for DENV-1-3 and
242                      Anticentromere antibody seropositivity was a significant, independent, protectiv
243                                          CMV seropositivity was also associated with impaired learnin
244                           In particular, CMV seropositivity was an independent risk factor for cardio
245                                              Seropositivity was associated with a reduced cervical bu
246                               However, HSV-2 seropositivity was associated with a shorter time to the
247                                          CMV seropositivity was associated with an increased risk of
248                                       HTLV-1 seropositivity was associated with female sex, older age
249                                       HTLV-2 seropositivity was associated with female sex, older age
250                                 However, CMV seropositivity was associated with higher levels of prev
251                    Among older adults, HSV-1 seropositivity was associated with immediate memory impa
252                                              Seropositivity was associated with improved patient surv
253                       Parental Toxocara spp. seropositivity was associated with increased offspring a
254 fspring than parents; however, Toxocara spp. seropositivity was associated with increased risk of all
255                       Donor or recipient CMV seropositivity was associated with increased risk of CMV
256                        Among children, HSV-1 seropositivity was associated with lower reading and spa
257                         For HPV-18, although seropositivity was associated with lower risk of ASCUS+
258 seropositive but MCV-seronegative, and HPyV7 seropositivity was associated with prolonged glucocortic
259                                Toxocara spp. seropositivity was associated with wheeze (2.97[1.45- 7.
260 and crypt depth measurements showed that HEV seropositivity was associated with worse enteropathy (P
261                                          HIV seropositivity was associated with worse outcomes overal
262 e screened by recombinant ELISA and MERS-CoV seropositivity was confirmed by recombinant immunofluore
263                                              Seropositivity was defined as an hSBA titer of 4 or high
264                          Helicobacter pylori seropositivity was defined as those positive to >/= 4 an
265                               C. trachomatis seropositivity was detected in 90% of the infected group
266 oped hepatobiliary cancer, the prevalence of seropositivity was higher: 100% for gallbladder cancer,
267                                    HPV-16 L1 seropositivity was highly associated with oropharyngeal
268               In multivariable analyses, HIV seropositivity was independently associated with mortali
269                                    H. pylori seropositivity was inversely associated with onset of as
270                                     HPV16 E6 seropositivity was less common for cancers of the cervix
271 positivity through age 15-16 years; however, seropositivity was less frequent among those starting va
272                                              Seropositivity was lower among males than among females
273                                              Seropositivity was maintained at month 12.
274                                     HPV16 E6 seropositivity was present in 29.2% of individuals (seve
275                                     HPV16 E6 seropositivity was present in prediagnostic samples for
276                                     HPV16 E6 seropositivity was present more than 10 years before dia
277 on Into Cancer and Nutrition study, HPV16 E6 seropositivity was present more than 10 years before oro
278                        The prevalence of EBV seropositivity was significantly increased among females
279                                              Seropositivity was significantly lower in participants c
280            In multivariable analyses, HPV-16 seropositivity was significantly more common in WSM vs M
281                                      Measles seropositivity was uniformly high in the US population d
282                                              Seropositivity was very strongly associated with improve
283                 Among asymptomatic contacts, seropositivity was weakly correlated with exposure level
284 tigate factors associated with cutaneous HPV seropositivity, we conducted a cross-sectional study of
285 V infection, and herpes simplex virus type 2 seropositivity were also predictive of incident HIV infe
286 -2.19] for OSCC risk, and GT/GG and HPV16 L1 seropositivity were associated with an OR of 2.81 (95% C
287 rus (CMV) and herpes simplex virus 1 (HSV-1) seropositivity were associated with cognitive impairment
288      Among middle-aged adults, HSV-1 and CMV seropositivity were associated with impaired coding spee
289 hic and lifestyle factors with cutaneous HPV seropositivity were estimated using odds ratios and 95%
290        Factors significantly associated with seropositivity were having skin wounds, sores, or ulcers
291 rted between 12 and 24 weeks of age, odds of seropositivity were increased 13.7 times (95% CI 3.1-60.
292 ariate analyses, factors associated with HEV seropositivity were increasing age (P-trend<0.001), birt
293  Independent risk factors for HCV subtype 4r seropositivity were intramuscular tuberculosis therapy,
294                                   JC and TSV seropositivity were more common among men than among wom
295           In addition, the associations with seropositivity were similar across smoking and/or drinki
296 edictors of rubella seroprotection and mumps seropositivity were similar.
297 onversion within 1 year (n=45), new anti-HCV seropositivity with clinical acute hepatitis (n=21), or
298                     We also assessed odds of seropositivity with respect to age of ART initiation and
299 a susceptibility locus (rs41270488) for HPV8 seropositivity within the major histocompatibility compl
300        We hypothesized, therefore, that HCMV seropositivity would be associated with altered NK cell

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top